Clinical Trial Supply and Logistics Strategic Business Report and Tariff Impact Analysis 2025: Analysis of Cost and Supply Chain Implications [Yahoo! Finance]
ArcBest Corporation (ARCB)
Last arcbest corporation earnings: 1/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
arcb.com/investor-relations
Company Research
Source: Yahoo! Finance
Dublin, April 24, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trial Supply and Logistics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Clinical Trial Supply and Logistics was valued at US$3.8 Billion in 2024 and is projected to reach US$5.2 Billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Clinical Trial Supply and Logistics market. Global Clinical Trial Supply and Logistics Market - Key Trends and Drivers Summarized Recent advancements in clinical trial supply and logistics are significantly enhancing efficiency and reliability. Technology integration, such as real-time tracking and monitoring systems, has improved the visibility and management of supply chains, enabling
Show less
Read more
Impact Snapshot
Event Time:
ARCB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARCB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARCB alerts
High impacting ArcBest Corporation news events
Weekly update
A roundup of the hottest topics
ARCB
News
- ArcBest (NASDAQ:ARCB) had its price target raised by analysts at Bank of America Corporation from $72.00 to $84.00. They now have a "neutral" rating on the stock.MarketBeat
- ArcBest (ARCB): Buy, Sell, or Hold Post Q3 Earnings? [Yahoo! Finance]Yahoo! Finance
- ArcBest (NASDAQ:ARCB) had its price target raised by analysts at Stifel Nicolaus from $73.00 to $85.00. They now have a "buy" rating on the stock.MarketBeat
- ArcBest: Stay Bullish That ARCB Can Hit Its EPS Guide [Seeking Alpha]Seeking Alpha
- ArcBest (NASDAQ:ARCB) had its price target lowered by analysts at Citigroup Inc. from $87.00 to $83.00. They now have a "buy" rating on the stock.MarketBeat
ARCB
Earnings
- 11/5/25 - Miss
ARCB
Sec Filings
- 12/9/25 - Form 4
- 12/1/25 - Form 8-K
- 11/26/25 - Form 8-K
- ARCB's page on the SEC website